Brown Brothers Harriman & Co. Sells 1,925 Shares of Sanofi (NASDAQ:SNY)

Brown Brothers Harriman & Co. cut its position in Sanofi (NASDAQ:SNY) by 29.3% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 4,648 shares of the company’s stock after selling 1,925 shares during the period. Brown Brothers Harriman & Co.’s holdings in Sanofi were worth $226,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in SNY. POM Investment Strategies LLC acquired a new stake in Sanofi during the 2nd quarter worth $25,000. Frazier Financial Advisors LLC acquired a new stake in shares of Sanofi during the fourth quarter worth about $28,000. Larson Financial Group LLC lifted its holdings in shares of Sanofi by 480.8% during the 1st quarter. Larson Financial Group LLC now owns 604 shares of the company’s stock valued at $29,000 after purchasing an additional 500 shares in the last quarter. Register Financial Advisors LLC acquired a new position in shares of Sanofi in the 1st quarter valued at approximately $29,000. Finally, Johnson Financial Group Inc. bought a new stake in Sanofi during the 4th quarter worth approximately $31,000. 10.04% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on SNY. StockNews.com lowered shares of Sanofi from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, September 11th. Argus boosted their price objective on shares of Sanofi from $55.00 to $60.00 and gave the company a “buy” rating in a research report on Friday, July 26th. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $57.50.

Sanofi Trading Up 1.0 %

NASDAQ SNY opened at $57.47 on Thursday. Sanofi has a 52 week low of $42.63 and a 52 week high of $58.97. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.65 and a current ratio of 1.00. The stock’s 50 day moving average price is $54.08 and its two-hundred day moving average price is $50.35. The stock has a market capitalization of $145.56 billion, a price-to-earnings ratio of 28.88, a PEG ratio of 1.60 and a beta of 0.60.

Sanofi (NASDAQ:SNY) last announced its quarterly earnings data on Thursday, July 25th. The company reported $0.93 EPS for the quarter, topping analysts’ consensus estimates of $0.88 by $0.05. The business had revenue of $10.75 billion for the quarter, compared to analyst estimates of $16.86 billion. Sanofi had a net margin of 9.60% and a return on equity of 26.29%. The firm’s revenue for the quarter was up 7.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.95 earnings per share. As a group, analysts anticipate that Sanofi will post 4.25 earnings per share for the current fiscal year.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.